GNCA

Genocea Biosciences, Inc.
GNCA

Overview Fund Activity
Delisted

GNCA was delisted on the 2nd of June, 2022.

Back to rankings

48 hedge funds and large institutions have $38.5M invested in Genocea Biosciences, Inc. in 2018 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 15 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
48
Holders Change
-6
Holders Change %
-11.11%
% of All Funds
1.1%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
8
Increased
7
Reduced
15
Closed
14
Calls
$1.21M
Puts
–
Net Calls
+$1.21M
Net Calls Change
-$89K

Top Buyers

1
FI
Fosun International
China
$323K
2
DS
DRW Securities
Illinois
$366K
3
PAM
Panagora Asset Management
Massachusetts
$97K
4
Renaissance Technologies
Renaissance Technologies
New York
$155K
5
SAM
Sectoral Asset Management
Quebec, Canada
$26K

Top Sellers

1
Alyeska Investment Group
Alyeska Investment Group
Illinois
$0
2
PP
Paloma Partners
Connecticut
$0
3
Millennium Management
Millennium Management
New York
$443K
4
LP
LMR Partners
United Kingdom
$8K
5
BCM
BlueCrest Capital Management
Jersey
$76K
Name Holding Trade Value Shares
Change 		Shares
Change %
D.E. Shaw & Co
51
D.E. Shaw & Co
New York
– -$25K -3,711 Closed
Two Sigma Advisers
52
Two Sigma Advisers
New York
– -$19K -2,785 Closed
LPL Financial
53
LPL Financial
California
– -$9K -1,277 Closed
Barclays
54
Barclays
United Kingdom
– -$4K -543 Closed
MAM
55
Meeder Asset Management
Ohio
– -$2.26K -330 Closed
TIM
56
Tortoise Investment Management
New York
– -$1K -105 Closed
1 2
3